[Targeted therapy for primary hepatocellular carcinoma].
Ye
Sheng-long
SL
D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D066246:ErbB Receptors / Q000008:administration & dosage*; D015316:Genetic Therapy; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*
D066246:ErbB Receptors